Hims & Hers Health, INC Form 4 insider transactions

Mohamed Elshenawy, CTO of Hims & Hers Health, Inc., received 1,200,000 shares of common stock on August 12, 2026.

Kare Schultz, a Director of Hims & Hers Health, Inc., received 8,223 shares of common stock on August 12, 2026.

Garcia Andrea G Perez, a Director of Hims & Hers Health, Inc., received 8,223 shares of common stock on August 12, 2026.

Anja Manuel, a Director of Hims & Hers Health, Inc., received 8,223 shares of common stock on August 12, 2026.

Patrick Harrison Carroll, Chief Medical Officer of Hims & Hers Health, Inc., received 260 shares of common stock on August 12, 2026.

David B Wells, a Director of Hims & Hers Health, Inc., reported multiple transactions in common stock on August 12, 2026.

Oluyemi Okupe, Chief Financial Officer of Hims & Hers Health, Inc., sold 7,163 shares of common stock on July 17, 2026 for $31.99 per share.

Hims & Hers Health, Inc. Chief Financial Officer, Oluyemi Okupe, reported the sale of 7,163 shares of Class A Common Stock for an average price of $36.4863, executed under a pre-arranged Rule 10b5-1 trading plan.

Chief Medical Officer Patrick Harrison Carroll acquired 25,926 shares of Hims & Hers Health, Inc. through RSU vesting, with 8,310 shares withheld for taxes.

Hims & Hers Health, Inc. CFO Oluyemi Okupe reported the vesting of restricted stock units and subsequent tax-related share withholding.

Chief Policy Officer Deborah M. Autor exercised restricted stock units and sold shares to cover tax obligations.

Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported the vesting of restricted stock units and subsequent sale of shares under a Rule 10b5-1 plan.

Hims & Hers Health, Inc. PAO Irene Becklund reported the vesting of restricted stock units and subsequent sale of shares under a Rule 10b5-1 plan.

Chief Legal Officer Soleil Boughton acquired 42,261 shares via RSU vesting, with 23,315 shares withheld for tax obligations.

CEO Andrew Dudum acquired 154,991 shares of Hims & Hers Health, Inc. through RSU vesting, with 85,632 shares withheld for taxes.

Mohamed Elshenawy, CTO of Hims & Hers Health, Inc., reported the vesting of RSUs and subsequent sale of shares via a 10b5-1 plan.

Director David B. Wells acquired 4,613 shares of Hims & Hers Health, Inc. through the vesting and conversion of restricted stock units.

Director Kare Schultz acquired 3,656 shares of Hims & Hers Health, Inc. through the vesting of restricted stock units.

Director Andrea G. Perez Garcia acquired 3,656 shares of Hims & Hers Health, Inc. Class A Common Stock through the vesting of restricted stock units.

Chief Medical Officer Patrick Harrison Carroll acquired 4,091 shares of Hims & Hers Health, Inc. through the vesting of restricted stock units.

Chief Policy Officer Deborah M. Autor acquired 3,656 shares of Hims & Hers Health, Inc. through the vesting of restricted stock units.

Director Christopher D. Payne acquired 14,343 shares of Hims & Hers Health, Inc. through the vesting of Restricted Stock Units.

Director Christiane Pendarvis acquired 3,656 shares of Hims & Hers Health, Inc. Class A Common Stock through the vesting of restricted stock units.

Director Anja Manuel acquired 13,696 shares of Hims & Hers Health, Inc. through the vesting and conversion of restricted stock units.

Director Delos M. Cosgrove acquired 3,656 shares of Hims & Hers Health, Inc. Class A Common Stock through the vesting of restricted stock units.

Director David B. Wells reported a purchase of 48,400 shares of Hims & Hers Health, Inc. Class A Common Stock on May 26, 2026.

Chief Medical Officer Patrick Harrison Carroll received 435 restricted stock units in lieu of cash director fees.

Director Christopher D. Payne was granted 647 restricted stock units in lieu of cash compensation for Q1 2026.

Director David B. Wells received 957 restricted stock units in lieu of cash compensation for Q1 2026 director fees.

Chief Financial Officer Oluyemi Okupe exercised 7,950 stock options and sold the resulting shares under a pre-established Rule 10b5-1 trading plan.